-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Observe Medical Annual Report for 2023
30 Apr 2024 21:38 CEST
Oslo, 30 April 2024 - Observe Medical ASA ("the Company" or "Observe Medical")
today announces that the Company has published its Annual Report for 2023. The
Annual Report was approved by the Board of Directors on 26 April 2024.
"Despite some challenges, 2023 was a year of great achievements and exciting
opportunities. I am grateful for the dedication of the Observe Medical team and
the continued support of our shareholders. Our ambition and goals for the future
remain unchanged, and I look forward to updating you on our progress soon"
commented Jørgen Mann, Interim CEO of Observe Medical.
The Annual Report for 2023 is attached to this notice and available on the
Company's website under the Investor Relations section. The auditor's report,
which is incorporated in the annual report, includes a statutory emphasis of
matter relating to the further financing of the Company.
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, Interim CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.
Further information is available at www.observemedical.com.
More information:
Access the news on Oslo Bors NewsWeb site
617431_Observe_Medical_Annual_Report_2023.pdf
617431_Observemedicalasa_2023_12_31_en.zip
Source
Observe Medical ASA
Provider
Oslo Børs Newspoint
Company Name
OBSERVE MEDICAL
ISIN
NO0010865009, NO0013457952
Symbol
OBSRV
Market
Euronext Expand